CORRECTING and REPLACING -- Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
17 févr. 2016 08h47 HE
|
Alcobra Ltd.
Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline...
Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
17 févr. 2016 08h00 HE
|
Alcobra Ltd.
Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Host Corporate Update Conference Call & Webcast on February 17
02 févr. 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences
28 janv. 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Added to the NASDAQ Biotechnology Index
17 déc. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Participate in Piper Jaffray 27th Annual Healthcare Conference
24 nov. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences Company Will Host Corporate Update Conference Call & Webcast on November 17
16 nov. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. Prices Public Offering of Ordinary Shares
13 nov. 2015 08h45 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,175,000 ordinary shares at an...
Alcobra Ltd. Announces Proposed Public Offering of Ordinary Shares
12 nov. 2015 16h05 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. Jefferies LLC and...
Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update
12 nov. 2015 16h01 HE
|
Alcobra Ltd.
Conference Call & Webcast November 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
The company provides an update on its Fragile X Syndrome development program
TEL AVIV, Israel,...